Latest Insider Transactions at Corbus Pharmaceuticals Holdings, Inc. (CRBP)
This section provides a real-time view of insider transactions for Corbus Pharmaceuticals Holdings, Inc. (CRBP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Corbus Pharmaceuticals Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Corbus Pharmaceuticals Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2020
|
Sean F. Moran Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,923
+8.72%
|
$0
$0.17 P/Share
|
|
Nov 11
2020
|
Yuval Cohen Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
4,240
+5.33%
|
$4,240
$1.21 P/Share
|